menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Medical Devices & Supplies
      • Pharmaceuticals
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Companies ➤ QIAGEN NV Company Profile

QIAGEN NV Company Profile

logo

QIAGEN NV

Technology

  • Type

    Public

  • Headquarters

    Netherlands

  • Founded

    1996

  • Key Management

    Mr.Thierry Bernard(CEO)

  • Revenue

    ~1,986.3(2021)

  • Headcount

    ~6000(2021)

  • Website

    www.qiagen.com

Business Description

 

QIAGEN NV offers Sample insight solutions to allow customers to gain valuable molecular insights from samples that contain essential building blocks of living things. Metin Kolpan and Detlev H.Riesner founded the company in April 1996. Its headquarters are in Venlo (the Netherlands). The company’s sample technologies extract DNA, RNA, and proteins from blood, tissues, and other materials.

The firm’s assay technology can see these biomolecules and make them available for analysis. Bioinformatics software, knowledge base, and bioinformatics program interpret data to give relevant and actionable insights. Firm automation solutions connect these solutions in seamless, efficient workflows. QIAGEN provides solutions for Molecular Diagnostics, Life Sciences (pharma R&D, academia), and Industrial Applications (primarily forensics).

 

Key Financials

 

Revenue (US$ Mn):

 

  • QIAGEN NV’s annual revenue for 2021 was US$ 1,986 Mn, a 6.22% increase from 2020.
  • The annual revenue generated by QIAGEN NV in 2020 was US$ 1,870 Mn.
  • At a 1.6% increase, QIAGEN NV’s annual revenue of US$ 1,526 Mn was indexed in 2019.
  • QIAGEN NV generated total revenue of US$ 1,502 Mn in 2018.

 

Operating Income (US$ Mn):

 

  • US$ 625 Mn was the operating income generated by QIAGEN NV in 2021
  • QIAGEN NV’s operating income for 2020 was US$ 537 Mn, a 71.02% increase from 2019
  • From 2018’s operating incomes, QIAGEN NV registered a 17.6% increase in 2019, amounting to US$ 314 Mn
  • An operating income of US$ 267 Mn was generated in 2018 by QIAGEN NV

 

Net Income (US$ Mn):

 

  • QIAGEN NV’s net income for 2021 was US$ 512 Mn, a 42.62% increase from 2020
  • The net income generated by QIAGEN NV in 2020 was US$ 359 Mn
  • At a -121.58% decrease, QIAGEN NV’s net income of US$ -41 Mn was indexed in 2019
  • QIAGEN NV generated a net income of US$ 190 Mn in 2018

 

Operating Margin %:

 

  • 31% was the operating margin generated by QIAGEN NV in 2021
  • QIAGEN NV’s operating margin for 2020 was 29%, a 40% increase from 2019
  • From 2018’s operating margins, QIAGEN NV registered a 15.17% increase in 2019, amounting to 21%
  • An operating margin of 18% was generated in 2018 by QIAGEN NV

 

Gross Margin %:

 

  • QIAGEN NV’s gross margin for 2021 was 26%, a 29.15% increase from 2020
  • The gross margin generated by QIAGEN NV in 2020 was 20%
  • At a -79.37% decrease, QIAGEN NV’s gross margin of 3% was indexed in 2019
  • QIAGEN NV generated a gross margin of 13% in 2018

 

SWOT Analysis

 

Strength

A diverse customer base insulates the company from concentration risks

QIAGEN serves a wide range of customers. The company sells samples, products, and assay kits (also known as consumables or automated instrumentation systems) to four main customer groups: molecular diagnostics; applied testing; pharmaceuticals; and academia. Customers of the company’s molecular diagnosis customers include healthcare providers who support many aspects of patient care. Qiagen’s customers in applied testing include those who use molecular technology in areas such as forensics and veterinary diagnostics. Its pharmaceutical customers include biotechnology and pharmaceutical companies. While its academic customers are researchers.

 

 

Get this premium content

The Premium data is Locked
Buy Now to Unlock Premium Data

Table of Content

  1. Business Description
  2. Key Financials
  3. SWOT Analysis
    1. Strength
      1. Diverse customer base insulating the company from concentration risks
      2. Strong commercial infrastructure
    2. Weaknesses
      1. Dependence on US
    3. Opportunities
      1. Expanding business operations through strategic initiatives
      2. Qiagen would benefit from the launch of new products to generate incremental revenue
    4. Threats
      1. Reduction in R&D budgets and government funding could affect the company's results of operations
      2. The company could be restricted by time-consuming and costly regulatory processes that could hinder its ability to generate sales
    5. Key Developments
      1. Year 2021
      2. Year 2020
      3. Year 2019
  • US $299
  • US $499
Buy Now
✖

Request For Company Data

We'll get back to you as quickly as possible

Primary Sidebar

  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library
Secured Payment Options
Secured Payment Options

© 2023 Market.Us. All Rights Reserved.